LAURA DAVIS: Open Payments
NPI 1366693905 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 93 payments from 26 companies in 2025. Trend: 2023 $858 · 2024 $1,369 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $304 |
| Vanda Pharmaceuticals Inc. | 12 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $135 |
| Novo Nordisk Inc | 6 | $97 |
| Lilly USA, LLC | 5 | $96 |
| PFIZER INC. | 4 | $75 |
| Verona Pharma, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Alkermes, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, MOUNJARO, REXULTI, Ohtuvayre, PREVNAR 20, Rybelsus.
Industry payments across KY — which companies pay providers there.
